EVALUATING CHOLESTEROL SCREENING - THE IMPORTANCE OF CONTROLLING FOR REGRESSION TO THE MEAN

被引:18
作者
FORROW, L
CALKINS, DR
ALLSHOUSE, K
HOROWITZ, G
DELBANCO, TL
机构
[1] BETH ISRAEL HOSP, DEPT MED, DIV GEN MED & PRIMARY CARE, BOSTON, MA 02215 USA
[2] HARVARD UNIV, SCH MED, CHARLES A DANA RES INST, HARVARD THORNDIKE LAB, BOSTON, MA 02115 USA
[3] BETH ISRAEL HOSP, DEPT PATHOL, BOSTON, MA 02215 USA
关键词
D O I
10.1001/archinte.155.20.2177
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: To determine the overall impact of a voluntary cholesterol screening program and to assess the importance of controlling for regression to the mean when evaluating the impact on higher-risk subgroups. Design: Longitudinal study comparing baseline survey and cholesterol results with those obtained 17 months later, with adjustment for regression to the mean. Setting: Participants were seen at three sites: an academic teaching hospital, an intermediate-care hospital, and a suburban community center. Participants: One thousand fifty-three participants were enrolled in a voluntary cholesterol screening program. Measurements/Main Results: Of 1053 study enrollees, 785 (75%) completed a follow-up questionnaire and 656 (62%) returned for follow-up cholesterol tests. Among all participants at high risk, measured cholesterol levels were 0.66 mmol/L (25.5 mg/dL) lower at follow-up, but 58% of this apparent change (0.38 mmol/L [14.7 mg/dL]) was attributable to the statistical phenomenon of regression to the mean. Among all participants at increased (both high and moderate) risk, after controlling for regression to the mean, reductions in cholesterol levels were significant for those younger than 60 years (-0.28 mmol/L [-10.8 mg/dL]; 95% confidence interval, -0.43 to -0.13; n=390) but not for those 60 years or older (+0.007 mmol/L [+0.3 mg/dL]; 95% confidence interval, -0.16 to +0.17; n=266). Conclusions: For subjects found at high risk in a cholesterol screening program, more than half of the apparent beneficial change in cholesterol level is attributable to regression to the mean. For participants older than 60 years, no clear benefit of cholesterol screening was documented.
引用
收藏
页码:2177 / 2184
页数:8
相关论文
共 41 条
  • [31] WOOLHANDLER S, 1988, Journal of the American Medical Association, V259, P2872, DOI 10.1001/jama.259.19.2872
  • [32] POPULATION SCREENING FOR PLASMA-CHOLESTEROL - COMMUNITY-BASED RESULTS FROM CONNECTICUT
    WYNDER, EL
    HARRIS, RE
    HALEY, NJ
    [J]. AMERICAN HEART JOURNAL, 1989, 117 (03) : 649 - 656
  • [33] POPULATION SCREENING FOR CHOLESTEROL DETERMINATION - A PILOT-STUDY
    WYNDER, EL
    FIELD, F
    HALEY, NJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20): : 2839 - 2842
  • [34] PRESCRIBED USE OF CHOLESTEROL-LOWERING DRUGS IN THE UNITED-STATES, 1978 THROUGH 1988
    WYSOWSKI, DK
    KENNEDY, DL
    GROSS, TP
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1990, 263 (16): : 2185 - 2188
  • [35] [No title captured]
  • [36] 1988, ARCH INTERN MED, V148, P36
  • [37] 1985, HLTH CONSEQUENCES SM
  • [38] 1990, MWWR MORBID MORTAL W, V39, P633
  • [39] 1988, MONTHLY VITAL STAT S, V37
  • [40] 1988, SAS SYSTEM RELEASE 6